Association of abnormal NDUFB2 and UQCRH expression with venous thromboembolism in patients with liver cirrhosis

Yixuan Tan,Yanhong Ma,Suzhi Guo,Yaoting Lin

DOI: https://doi.org/10.1097/md.0000000000036868

IF: 1.6

2024-01-11

Medicine

Abstract:Venous thromboembolism (VTE) is a dangerous chronic disease that includes deep venous thrombosis (DVT) and pulmonary thromboembolism (PTE). According to statistics, about 90% of the emboli in PTE come from the deep venous system of the lower extremities, while thrombosis from other parts is rare. Therefore, effective prevention of lower limb DVT can effectively prevent PTE. [ 1–3 ] Venous thromboembolism is a common disease with multiple factors and high mortality. First of all, the abnormal increase of coagulation factors is easy to induce thrombosis. Secondly, intimal injury will lead to the release of a large number of procoagulant factors, leading to formation of intravascular thrombus. Third, there is hypercoagulable state, especially in patients with tumor or nephrotic syndrome. [ 4 , 5 ] The incidence of VTE is increasing in China. [ 6–8 ] Although the mortality of DVT and PTE is declining, VTE is still third leading cause of death worldwide. The disease has become a major global health problem and has aroused widespread concern in the international academic community and society. However, the cause of venous thromboembolism is unclear. Therefore, it is important to study molecular mechanism of venous thromboembolism.

medicine, general & internal